Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]

The Role of General Practitioners in Early Detection of Inflammatory Bowel Disease

10 months ago
As its name suggests, inflammatory bowel disease (IBD), which encompasses ulcerative colitis and Crohn’s disease, involves chronic inflammation of the digestive tract. IBD is a common disease in the West, afflicting more than 5 million people.2 Although IBD is still rare in Southeast Asia, the incidence appears to be on the rise in Malaysia, with a rate of 0.67 per 100,000 population.3 It is noteworthy that early detection and management of IBD can reduce a significant amount of pain and stress for patients. Thus, general practitioners (GPs), who are experts trained to work in the front line of a healthcare system, play a vital role in reducing the burden of IBD through immediate referral of suspected IBD patients for specialist investigations.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
one year ago
Cetuximab as third line therapy provided survival benefits and maintained quality of life in patients with metastatic colorectal cancers (mCRC) who responded unsuccessfully to prior chemotherapy, a study conducted in a single institution has shown.
Jairia Dela Cruz, 6 months ago
Regimens containing sofosbuvir and velpatasvir are the best option for treating patients with hepatitis C virus (HCV) genotype 3 infection, according to the results of a network meta-analysis. Furthermore, ribavirin should be considered in select patients as the agent produces significant increases in sustained virological response (SVR) rates.
one year ago
Daily oral HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate may be safe in hepatitis B virus (HBV)-infected individuals, a study reported.
Pearl Toh, one year ago
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]